Lisa Shea is the Scientific Patient Engagement Leader for Janssen Scientific Affairs. Lisa is responsible for bringing the patient perspective in-house and leveraging it to drive high priority patient-centered activities from the earliest stages of strategy development to final stages of project execution. She will lead the strategic development and execution of patient-centered research and engagement from within Janssen Scientific and Medical Affairs and with partners across North America Pharmaceuticals and Janssen.
Previously, Lisa spent four years leading the strategy and operations for the Integrated Evidence Generation Planning (IEGP) and Integrated Evidence Team Leader (IETL) community, working seamlessly with internal stakeholders to operationalize IEGPs across all Integrated Evidence Teams (IETs) while driving connectivity across the scientific community.
Prior to joining Johnson & Johnson, Lisa worked in Public Policy at GlaxoSmithKline. She was a Health Policy Liaison in U.S. Medical Affairs where she led external engagement planning with evidence-generating agencies such as the Patient-Centered Outcomes Research Institute (PCORI). She also helped embed the patient voice into various phases of the study life cycle while strengthening internal capabilities across the Commercial business and R&D, including the Patient Advocacy teams.
Lisa holds a master’s degree in public health from Drexel University in Philadelphia, Pennsylvania, and has more than 15 years of experience in the health care industry. She is a Registered Dietitian, working in both the acute care and long-term care hospital settings, and a Project Lead in the design of a novel community-based participatory research project to improve nutrition and exercise outcomes across three school districts in suburban Philadelphia.